Affinity Asset Advisors

Affinity Asset Advisors as of March 31, 2022

Portfolio Holdings for Affinity Asset Advisors

Affinity Asset Advisors holds 56 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 54.2 $339M 750k 451.64
Springworks Therapeutics (SWTX) 3.7 $23M 407k 56.44
Inari Medical Ord (NARI) 3.2 $20M 220k 90.64
Morphic Hldg (MORF) 3.0 $19M 466k 40.15
Kura Oncology (KURA) 2.4 $15M 924k 16.08
Ascendis Pharma A/s Sponsored Adr (ASND) 2.3 $14M 120k 117.36
Chinook Therapeutics 2.2 $14M 845k 16.36
Protagonist Therapeutics (PTGX) 2.0 $12M 516k 23.68
Establishment Labs Holdings Ord (ESTA) 1.9 $12M 175k 67.39
Travere Therapeutics Note 2.500% 9/1 (Principal) 1.8 $12M 11M 1.04
Astrazeneca Sponsored Adr (AZN) 1.7 $11M 160k 66.34
Zentalis Pharmaceuticals (ZNTL) 1.5 $9.6M 208k 46.14
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 1.4 $8.6M 155k 55.31
Nanostring Technologies Note 2.625% 3/0 (Principal) 1.2 $7.8M 7.0M 1.11
Madrigal Pharmaceuticals (MDGL) 1.2 $7.4M 75k 98.12
Arya Sciences Acquisitn Corp Class A Ord Shs 1.1 $6.8M 703k 9.72
Repare Therapeutics Ord (RPTX) 1.1 $6.7M 469k 14.24
Pmv Pharmaceuticals Call Option (PMVP) 1.1 $6.6M 317k 20.82
Nanostring Technologies (NSTGQ) 1.0 $6.0M 172k 34.75
Vincerx Pharma Com New (VINC) 0.9 $5.5M 1.4M 4.00
Rocket Pharmaceuticals (RCKT) 0.8 $4.8M 300k 15.86
Bridgebio Pharma Note 2.250% 2/0 (Principal) 0.7 $4.7M 10M 0.47
Bridgebio Pharma Note 2.500% 3/1 (Principal) 0.7 $4.4M 7.5M 0.58
Celldex Therapeutics Com New (CLDX) 0.7 $4.3M 125k 34.06
Bellus Health Com New 0.7 $4.1M 600k 6.88
Cymabay Therapeutics 0.6 $4.0M 1.3M 3.11
Crispr Therapeutics Namen Akt Call Option (CRSP) 0.6 $3.5M 55k 62.76
Horizon Therapeutics Pub L SHS 0.5 $3.2M 30k 105.20
Health Sciences Acq Corp 2 Ord Shs 0.5 $3.0M 300k 9.91
Medicus Sciences Acquisition Cl A Shs 0.5 $2.9M 300k 9.78
Travere Therapeutics (TVTX) 0.4 $2.6M 100k 25.77
Cerevel Therapeutics Hldng I (CERE) 0.4 $2.5M 70k 35.01
Xenon Pharmaceuticals (XENE) 0.4 $2.4M 80k 30.57
Nautilus Biotechnology (NAUT) 0.4 $2.4M 559k 4.34
Global Blood Therapeutics In 0.4 $2.4M 70k 34.64
Relay Therapeutics Call Option (RLAY) 0.4 $2.2M 75k 29.93
Aurinia Pharmaceuticals Call Option (AUPH) 0.3 $2.2M 175k 12.38
Aclaris Therapeutics (ACRS) 0.3 $1.7M 100k 17.24
Beam Therapeutics Call Option (BEAM) 0.3 $1.7M 30k 57.30
Context Therapeutics (CNTX) 0.3 $1.7M 778k 2.17
Cyclacel Pharmaceuticals 0.2 $1.2M 400k 3.05
Lianbio Sponsored Ads (LIANY) 0.2 $1.2M 325k 3.71
Science 37 Holdings 0.2 $1.2M 221k 5.35
Karuna Therapeutics Ord 0.2 $951k 7.5k 126.80
Miragen Therapeutics (VRDN) 0.1 $925k 50k 18.50
Athersys Put Option 0.1 $858k 1.4M 0.61
Renovacor 0.1 $846k 200k 4.24
Curis Com New 0.1 $833k 350k 2.38
Celularity Com Cl A Put Option 0.1 $697k 80k 8.71
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.1 $586k 65k 8.98
Calithera Biosciences 0.1 $404k 1.0M 0.40
Immatics *w Exp 07/01/202 (IMTXW) 0.1 $328k 187k 1.75
Hyperfine Com Cl A (HYPR) 0.0 $270k 76k 3.55
Blueprint Medicines (BPMC) 0.0 $127k 2.0k 63.88
Renovacor *w Exp 99/99/999 0.0 $26k 75k 0.35
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $14k 33k 0.42